Combining Imaging and Therapy in One Treatment Approach One of the most innovative aspects shaping the Radioligand Therapy (RLT) Market is the integration of diagnostics and treatment within a single framework known as theranostics. Theranostics combines imaging agents and therapeutic compounds targeting the same molecular receptor. Doctors first identify tumors using diagnostic scans and then deliver therapy using a similar targeting mechanism. This approach improves patient selection accuracy. Only individuals whose tumors express the required receptors proceed to treatment, reducing unnecessary exposure. Ref - https://www.marketresearchfuture.com/reports/radioligand-therapy-rlt-market-11824